Jennifer Whiteley

Jennifer Whiteley serves as an Affiliate Associate Professor in the Department of Pharmacy at the University of Washington School of Pharmacy and Head of Neuroscience & Rare Disease Evidence for Access (E4A) at Genentech, Inc., with additional affiliation to the CHOICE Institute (Comparative Health Outcomes, Policy, and Economics).

Her educational credentials include:

• EdD in Health & Behavior from Columbia University
• MSc in Epidemiology from London School of Hygiene and Tropical Medicine
• MA in Physiology from Columbia University

Her research centers on Health Economics and Outcomes Research (HEOR) with specialization in neuroscience and rare disease therapeutics, focusing on evidence generation frameworks for healthcare access and policy implementation. She integrates epidemiological methods with health policy analysis to address barriers in patient access to innovative treatments, particularly within neuropharmacology and orphan drug development.

No scientific awards were documented in the source material.

As an affiliate faculty member, she contributes to the academic mission of the School of Pharmacy through the CHOICE Institute's health outcomes research initiatives, though specific advising roles or grant details were not enumerated. Her industry leadership at Genentech drives cross-functional evidence generation strategies for market access.

She directs the Neuroscience & Rare Disease Evidence for Access (E4A) program at Genentech while maintaining active collaboration with the University of Washington's CHOICE Institute, which conducts high-impact research on healthcare value assessment and policy optimization.